133 related articles for article (PubMed ID: 18621136)
21. Diagnostic labeling of COPD in five Latin American cities.
Tálamo C; de Oca MM; Halbert R; Perez-Padilla R; Jardim JR; Muiño A; Lopez MV; Valdivia G; Pertuzé J; Moreno D; Menezes AM;
Chest; 2007 Jan; 131(1):60-7. PubMed ID: 17218557
[TBL] [Abstract][Full Text] [Related]
22. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population.
Lopez Varela MV; Montes de Oca M; Wehrmeister FC; Rodriguez C; Ramirez L; Menezes A
Int J Chron Obstruct Pulmon Dis; 2019; 14():1901-1911. PubMed ID: 31692595
[TBL] [Abstract][Full Text] [Related]
23. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
[TBL] [Abstract][Full Text] [Related]
24. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.
Menezes AM; Perez-Padilla R; Jardim JR; Muiño A; Lopez MV; Valdivia G; Montes de Oca M; Talamo C; Hallal PC; Victora CG;
Lancet; 2005 Nov; 366(9500):1875-81. PubMed ID: 16310554
[TBL] [Abstract][Full Text] [Related]
25. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.
Menezes AMB; Montes de Oca M; Pérez-Padilla R; Nadeau G; Wehrmeister FC; Lopez-Varela MV; Muiño A; Jardim JRB; Valdivia G; Tálamo C;
Chest; 2014 Feb; 145(2):297-304. PubMed ID: 24114498
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
[TBL] [Abstract][Full Text] [Related]
27. Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction?
Hansen JE; Sun XG; Wasserman K
Eur Respir J; 2006 Jun; 27(6):1244-50. PubMed ID: 16455822
[TBL] [Abstract][Full Text] [Related]
28. Six-second spirometry for detection of airway obstruction: a population-based study in Austria.
Lamprecht B; Schirnhofer L; Tiefenbacher F; Kaiser B; Buist SA; Studnicka M; Enright P
Am J Respir Crit Care Med; 2007 Sep; 176(5):460-4. PubMed ID: 17556719
[TBL] [Abstract][Full Text] [Related]
29. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities.
Menezes AM; Victora CG; Perez-Padilla R;
BMC Med Res Methodol; 2004 Jun; 4():15. PubMed ID: 15202950
[TBL] [Abstract][Full Text] [Related]
30. Significant bronchodilator responsiveness and "reversibility" in a population sample.
Prentice HA; Mannino DM; Caldwell GG; Bush HM
COPD; 2010 Oct; 7(5):323-30. PubMed ID: 20854046
[TBL] [Abstract][Full Text] [Related]
31. Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada.
Tan WC; Bourbeau J; FitzGerald JM; Cowie R; Chapman K; Hernandez P; Buist SA; Sin DD
Int J Tuberc Lung Dis; 2011 Dec; 15(12):1691-8. PubMed ID: 22118181
[TBL] [Abstract][Full Text] [Related]
32. Detection of wheezing during maximal forced exhalation in patients with obstructed airways.
Fiz JA; Jané R; Homs A; Izquierdo J; García MA; Morera J
Chest; 2002 Jul; 122(1):186-91. PubMed ID: 12114356
[TBL] [Abstract][Full Text] [Related]
33. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America.
Menezes AM; Hallal PC; Perez-Padilla R; Jardim JR; Muiño A; Lopez MV; Valdivia G; Montes de Oca M; Talamo C; Pertuze J; Victora CG;
Eur Respir J; 2007 Dec; 30(6):1180-5. PubMed ID: 17804445
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of lung volume response with airflow response to bronchodilator in patients with chronic obstructive pulmonary disease].
Zhang FQ; Zheng JP; Wang JH; Lu WB; Wu RX; Li XS; Xian QZ; Gao Y; Jiang M
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):109-13. PubMed ID: 20367950
[TBL] [Abstract][Full Text] [Related]
35. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
Walker PP; Calverley PM
COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
[TBL] [Abstract][Full Text] [Related]
36. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care.
Schermer TR; Smeele IJ; Thoonen BP; Lucas AE; Grootens JG; van Boxem TJ; Heijdra YF; van Weel C
Eur Respir J; 2008 Oct; 32(4):945-52. PubMed ID: 18550607
[TBL] [Abstract][Full Text] [Related]
37. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.
Troosters T; Celli B; Lystig T; Kesten S; Mehra S; Tashkin DP; Decramer M;
Eur Respir J; 2010 Jul; 36(1):65-73. PubMed ID: 20185426
[TBL] [Abstract][Full Text] [Related]
38. [FEV1 after three years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease].
Zagdańska R; Grzelewska-Rzymowska I
Pneumonol Alergol Pol; 2005; 73(2):142-7. PubMed ID: 16756143
[TBL] [Abstract][Full Text] [Related]
39. Bronchodilator responsiveness and reported respiratory symptoms in an adult population.
Tan WC; Bourbeau J; Hernandez P; Chapman KR; Cowie R; FitzGerald JM; Aaron S; Marciniuk DD; Maltais F; Buist AS; O'Donnell DE; Sin DD;
PLoS One; 2013; 8(3):e58932. PubMed ID: 23554960
[TBL] [Abstract][Full Text] [Related]
40. Multicity study of air pollution and mortality in Latin America (the ESCALA study).
Romieu I; Gouveia N; Cifuentes LA; de Leon AP; Junger W; Vera J; Strappa V; Hurtado-Díaz M; Miranda-Soberanis V; Rojas-Bracho L; Carbajal-Arroyo L; Tzintzun-Cervantes G;
Res Rep Health Eff Inst; 2012 Oct; (171):5-86. PubMed ID: 23311234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
